Navigation Links
Reportlinker Adds China In Vitro Diagnostics Market Outlook to 2016
Date:7/19/2010

NEW YORK, July 19 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

China In Vitro Diagnostics Market Outlook to 2016

http://www.reportlinker.com/p0240263/China-In-Vitro-Diagnostics-Market-Outlook-to-2016.html

China In Vitro Diagnostics Market Outlook to 2016

Summary

GlobalData's new report, "China In Vitro Diagnostics Market Outlook to 2016" provides key market data on the China In Vitro Diagnostics (IVD) market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within seven market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Market size and company share data for In Vitro Diagnostics (IVD) market categories – clinical chemistry, genetic testing, histology and cytology, immuno chemistry, infectious immunology, microbiology culture, and haematology.

- Annualized market revenues (USD million), volume (units) and average price (USD) data for each of the segments and sub-segments within seven market categories. Data from 2002 to 2009, forecast forward for 7 years to 2016.

- 2009 company shares and distribution shares data for each of the seven market categories.

- Global corporate-level profiles of key companies operating within the China In Vitro Diagnostics (IVD) market.

- Key players covered include Roche, Siemens Healthcare, Abbott, Beckman Coulter, Biomerieux, Ortho-Clinical Diagnostics, and Becton, Dickinson.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the China In Vitro Diagnostics (IVD) competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents 2

1.1 List of Tables 10

1.2 List of Figures 13

2 Introduction 16

2.1 What is This Report About? 16

3 In Vitro Diagnostics In China 17

3.1 In Vitro Diagnostics, Market Segmentation 17

3.2 In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 18

3.3 In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009 20

3.4 In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21

3.5 In Vitro Diagnostics, China, Company Share (2008-2009) 27

4 Clinical Chemistry In China 28

4.1 Clinical Chemistry, Market Segmentation 28

4.2 Clinical Chemistry Market, China, Revenue Mix ($m), 2009 29

4.3 Clinical Chemistry Market, China, Category Contribution (%), 2009 30

4.4 Clinical Chemistry Overall Revenue (2002-2016) 31

4.4.1 Clinical Chemistry Analyzers Revenue (2002-2016) 35

4.4.2 Urine Analysis Revenue (2002-2016) 39

4.5 Clinical Chemistry Distribution Share (2008-2009) 43

4.6 Clinical Chemistry, China, Company Share (2008-2009) 44

5 Genetic Testing In China 46

5.1 Genetic Testing, Market Segmentation 46

5.2 Genetic Testing Market, China, Revenue Mix ($m), 2009 47

5.3 Genetic Testing Market, China, Category Contribution (%), 2009 48

5.4 Genetic Testing Overall Revenue (2002-2016) 49

5.5 Genetic Testing Distribution Share (2008-2009) 53

5.6 Genetic Testing, China, Company Share (2008-2009) 54

6 Haematology In China 55

6.1 Haematology, Market Segmentation 55

6.2 Haematology Market, China, Revenue Mix ($m), 2009 56

6.3 Haematology Market, China, Category Contribution (%), 2009 57

6.4 Haematology Overall Revenue (2002-2016) 58

6.4.1 Haematology Reagents Revenue (2002-2016) 62

6.4.2 Immunohaematology Revenue (2002-2016) 66

6.4.3 Haemostasis Revenue (2002-2016) 70

6.4.4 Haematology Rapid Tests Revenue (2002-2016) 74

6.4.5 Haematology Cell Counters Revenue (2002-2016) 78

6.5 Haematology Distribution Share (2008-2009) 82

6.6 Haematology, China, Company Share (2008-2009) 83

7 Histology And Cytology In China 85

7.1 Histology and Cytology, Market Segmentation 85

7.2 Histology and Cytology Market, China, Revenue Mix ($m), 2009 86

7.3 Histology And Cytology Market, China, Category Contribution (%), 2009 87

7.4 Histology And Cytology Overall Revenue (2002-2016) 88

7.4.1 Histology Revenue (2002-2016) 92

7.5 Histology And Cytology Distribution Share (2008-2009) 96

7.6 Histology And Cytology, China, Company Share (2008-2009) 97

8 Immuno Chemistry In China 98

8.1 Immuno Chemistry, Market Segmentation 98

8.2 Immuno Chemistry Market, China, Revenue Mix ($m), 2009 99

8.3 Immuno Chemistry Market, China, Category Contribution (%), 2009 100

8.4 Immuno Chemistry Overall Revenue (2002-2016) 101

8.4.1 Disease Specific Immunochemistry Revenue (2002-2016) 105

8.4.2 Drug Related Testing Revenue (2002-2016) 109

8.4.3 Endocrinology Tests Revenue (2002-2016) 112

8.4.4 Immunochemistry Analyzers Revenue (2002-2016) 116

8.5 Immuno Chemistry Distribution Share (2008-2009) 120

8.6 Immuno Chemistry, China, Company Share (2008-2009) 121

9 Infectious Immunology In China 123

9.1 Infectious Immunology, Market Segmentation 123

9.2 Infectious Immunology Market, China, Revenue Mix ($m), 2009 124

9.3 Infectious Immunology Market, China, Category Contribution (%), 2009 125

9.4 Infectious Immunology Overall Revenue (2002-2016) 126

9.5 Infectious Immunology Distribution Share (2008-2009) 130

9.6 Infectious Immunology, China, Company Share (2008-2009) 131

10 Microbiology Culture In China 133

10.1 Microbiology Culture, Market Segmentation 133

10.2 Microbiology Culture Market, China, Revenue Mix ($m), 2009 134

10.3 Microbiology Culture Market, China, Category Contribution (%), 2009 135

10.4 Microbiology Culture Overall Revenue (2002-2016) 136

10.4.1 Microbiology Analyzers Revenue (2002-2016) 140

10.5 Microbiology Culture Distribution Share (2008-2009) 143

10.6 Microbiology Culture, China, Company Share (2008-2009) 144

11 Overview of Key Companies in China In Vitro Diagnostics Market 145

11.1 F. Hoffmann-La Roche Ltd. 145

11.1.1 Company Overview 145

11.1.2 Share in the China In Vitro Diagnostics Market 145

11.2 Siemens Healthcare 146

11.2.1 Company Overview 146

11.2.2 Share in the China In Vitro Diagnostics Market 146

11.3 Abbott Laboratories Company Overview 147

11.3.1 Share in the China In Vitro Diagnostics Market 147

11.4 Beckman Coulter, Inc. 148

11.4.1 Company Overview 148

11.4.2 Share in the China In Vitro Diagnostics Market 148

11.5 Sysmex Corporation 149

11.5.1 Company Overview 149

11.5.2 Share in the China In Vitro Diagnostics Market 149

11.6 Mindray Medical International Limited 150

11.6.1 Company Overview 150

11.6.2 Share in the China In Vitro Diagnostics Market 150

11.7 OLYMPUS CORPORATION 151

11.7.1 Company Overview 151

11.8 Inverness Medical Innovations, Inc. 151

11.8.1 Company Overview 151

11.9 Becton, Dickinson and Company 152

11.9.1 Company Overview 152

11.10 bioMerieux S.A. 152

11.10.1 Company Overview 152

11.11 Bio-Rad Laboratories, Inc. 153

11.11.1 Company Overview 153

11.12 Hologic, Inc. 153

11.12.1 Company Overview 153

11.13 Ventana Medical Systems, Inc. 154

11.13.1 Company Overview 154

11.14 Ortho-Clinical Diagnostics Inc. 154

11.14.1 Company Overview 154

11.15 DiaSorin S.p.A 154

11.15.1 Company Overview 154

11.16 Qiagen N.V. 155

11.16.1 Company Overview 155

11.17 Gen-Probe Incorporated 155

11.17.1 Company Overview 155

11.18 Phadia AB 155

11.18.1 Company Overview 155

11.19 Chengdu Perlong Medical Equipment Co., Ltd. 156

11.19.1 Company Overview 156

11.20 Shanghai Kehua Bio-engineering Co., Ltd. 156

11.20.1 Company Overview 156

11.21 China Medical Technologies, Inc. 156

11.21.1 Company Overview 156

11.22 Shanghai Genomics, Inc. 157

11.22.1 Company Overview 157

11.23 Beijing Chemclin Biotech Co., Ltd. 157

11.23.1 Company Overview 157

11.24 Beijing Pason Pharmaceuticals Inc. 157

11.24.1 Company Overview 157

11.25 Jingmei Biotech Co., Ltd. 158

11.25.1 Company Overview 158

11.26 Beijing Bio-Ekon Biotechnology Co., Ltd. 158

11.26.1 Company Overview 158

11.27 China Sky One Medical, Inc. 158

11.27.1 Company Overview 158

11.28 Beijing Sekisui Trank Medical Technology Co., Ltd. 159

11.28.1 Company Overview 159

11.29 Shanghai Xunda Medical Instrument Co., Ltd 159

11.29.1 Company Overview 159

11.30 Shanghai Fosun Medical Technology Development Co., Ltd. 159

11.30.1 Company Overview 159

11.31 Sichuan Nigale Biomedical Inc. 160

11.31.1 Company Overview 160

11.32 URIT Medical Electronic Group Co., Ltd 160

11.32.1 Company Overview 160

11.33 Rayto Life and Analytical Sciences Co., Ltd. 160

11.33.1 Company Overview 160

11.34 Bioson Corporation 161

11.34.1 Company Overview 161

11.35 Da An Gene Co., Ltd. 161

11.35.1 Company Overview 161

11.36 Shenzhen PG Biotech Co., Ltd. 161

11.36.1 Company Overview 161

11.37 Harbin First Bio-Engineering Co., Ltd 161

11.37.1 Company Overview 161

11.38 Beijing Shining Sun Technology Co., Ltd. 162

11.38.1 Company Overview 162

11.39 InTec Products, Inc 162

11.39.1 Company Overview 162

11.40 Zhongshan Bio-Tech Co., Ltd 162

11.40.1 Company Overview 162

11.41 Beijing BGI-GBI Biotech Co., Ltd. 162

11.41.1 Company Overview 162

11.42 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd., 163

11.42.1 Company Overview 163

11.43 GUANG ZHOU BGH BIOCHEMICAL CO., LTD 163

11.43.1 Company Overview 163

12 In Vitro Diagnostics Market Pipeline Products 164

12.1 Clinical Chemistry Market Pipeline Products 164

12.2 Immuno Chemistry Market Pipeline Products 166

12.3 Haematology Market Pipeline Products 167

12.4 Infectious Immunology Market Pipeline Products 168

12.5 Microbiology Culture Market Pipeline Products 170

12.6 Histology and Cytology Market Pipeline Products 171

12.7 Genetic Testing Market Pipeline Products 172

13 Financial Deals Landscape 174

13.1 Acquisition 174

13.1.1 CCS Capital to Acquire Beijing Biochem Hengye Science & Technology Development 174

13.1.2 bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175

13.1.3 PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176

13.2 Partnerships 177

13.2.1 QIAGEN Enters Into Distribution Agreement With Celera 177

13.2.2 Sequenom Enters Into Licensing Agreement With Optherion 178

13.2.3 QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179

13.2.4 Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech 180

13.2.5 OraSure Technologies Enters Into An Agreement With Roche Diagnostics 181

13.2.6 Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182

13.2.7 DxS Signs Cross-Licensing Agreement With Epigenomics 183

14 Recent Developments 184

14.1 Strategy and Business Planning 184

14.1.1 Sep 08, 2009: Qiagen Inaugurates New Asia Headquarters In Shanghai 184

14.2 Legal and Regulatory 184

14.2.1 Mar 08, 2010: Chinmax Medical Systems Files Complaint In China Against Inverness Medical Beijing Over Distribution Rights 184

14.3 Product News 185

14.3.1 Jun 09, 2010: China Medical Technologies Receives SFDA Approval For Its SPR-Based HPV-DNA Chip 185

14.3.2 Apr 14, 2010: HairDX Forms Alliance With GBIL To Distribute HairDX Genetic Hair Loss Tests In Hong Kong And Singapore 185

14.3.3 Dec 01, 2009: China Sky One Medical Distributes AMI Diagnostic Kit And Human Urinary Albumin Elisa Kit In Southeast Asia Through MDK 186

14.3.4 Nov 25, 2009: China Sky One Medical Achieves Milestone For Its Two New Biological Testing Kits 186

14.3.5 Oct 19, 2009: China Medical Technologies Receives SFDA Clearance For SPR System 187

15 Appendix 188

15.1 Definitions of Markets Covered in the Report 189

15.1.1 In Vitro Diagnostics 189

15.2 Research Methodology 197

15.3 Secondary Research 198

15.4 Primary Research 198

15.5 Models 199

15.6 Forecasts 199

15.7 Expert Panels 199

15.8 GlobalData Consulting 199

15.9 Currency Conversion 200

15.10 Contact Us 200

15.11 Disclaimer 200

1.1 List of Tables

Table 1: In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 19

Table 2: In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21

Table 3: In Vitro Diagnostics, China, Cross-Category Analysis, 2002-2016 22

Table 4: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2002-2009 24

Table 5: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2009-2016 26

Table 6: In Vitro Diagnostics, China, Company Share by Revenue ($m), 2008-2009 27

Table 7: Clinical Chemistry Market, China, Category Contribution (%), 2009 30

Table 8: Clinical Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 32

Table 9: Clinical Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 34

Table 10: Clinical Chemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 36

Table 11: Clinical Chemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 38

Table 12: Urine Analysis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 40

Table 13: Urine Analysis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 42

Table 14: Clinical Chemistry, China, Distribution Share by Revenue ($m), 2008-2009 43

Table 15: Clinical Chemistry, China, Company Share by Revenue ($m), 2008-2009 45

Table 16: Genetic Testing Market, China, Category Contribution (%), 2009 48

Table 17: Genetic Testing, China, Revenue ($m) by Segment, Historic, 2002-2009 50

Table 18: Genetic Testing, China, Revenue ($m) by Segment, Forecast, 2009-2016 52

Table 19: Genetic Testing, China, Distribution Share by Revenue ($m), 2008-2009 53

Table 20: Genetic Testing, China, Company Share by Revenue ($m), 2008-2009 54

Table 21: Haematology Market, China, Category Contribution (%), 2009 57

Table 22: Haematology, China, Revenue ($m) by Segment, Historic, 2002-2009 59

Table 23: Haematology, China, Revenue ($m) by Segment, Forecast, 2009-2016 61

Table 24: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 63

Table 25: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 65

Table 26: Immunohaematology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 67

Table 27: Immunohaematology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 69

Table 28: Haemostasis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 71

Table 29: Haemostasis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 73

Table 30: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 75

Table 31: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 77

Table 32: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 79

Table 33: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 81

Table 34: Haematology, China, Distribution Share by Revenue ($m), 2008-2009 82

Table 35: Haematology, China, Company Share by Revenue ($m), 2008-2009 84

Table 36: Histology And Cytology Market, China, Category Contribution (%), 2009 87

Table 37: Histology And Cytology, China, Revenue ($m) by Segment, Historic, 2002-2009 89

Table 38: Histology And Cytology, China, Revenue ($m) by Segment, Forecast, 2009-2016 91

Table 39: Histology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 93

Table 40: Histology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 95

Table 41: Histology And Cytology, China, Distribution Share by Revenue ($m), 2008-2009 96

Table 42: Histology And Cytology, China, Company Share by Revenue ($m), 2008-2009 97

Table 43: Immuno Chemistry Market, China, Category Contribution (%), 2009 100

Table 44: Immuno Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 102

Table 45: Immuno Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 104

Table 46: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 106

Table 47: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 108

Table 48: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109

Table 49: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 111

Table 50: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 113

Table 51: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 115

Table 52: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 117

Table 53: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 119

Table 54: Immuno Chemistry, China, Distribution Share by Revenue ($m), 2008-2009 120

Table 55: Immuno Chemistry, China, Company Share by Revenue ($m), 2008-2009 122

Table 56: Infectious Immunology Market, China, Category Contribution (%), 2009 125

Table 57: Infectious Immunology, China, Revenue ($m) by Segment, Historic, 2002-2009 127

Table 58: Infectious Immunology, China, Revenue ($m) by Segment, Forecast, 2009-2016 129

Table 59: Infectious Immunology, China, Distribution Share by Revenue ($m), 2008-2009 130

Table 60: Infectious Immunology, China, Company Share by Revenue ($m), 2008-2009 132

Table 61: Microbiology Culture Market, China, Category Contribution (%), 2009 135

Table 62: Microbiology Culture, China, Revenue ($m) by Segment, Historic, 2002-2009 137

Table 63: Microbiology Culture, China, Revenue ($m) by Segment, Forecast, 2009-2016 139

Table 64: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 141

Table 65: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 142

Table 66: Microbiology Culture, China, Distribution Share by Revenue ($m), 2008-2009 143

Table 67: Microbiology Culture, China, Company Share by Revenue ($m), 2008-2009 144

Table 68: Clinical Chemistry Market Pipeline Products 164

Table 69: Immuno Chemistry Market Pipeline Products 166

Table 70: Haematology Market Pipeline Products 167

Table 71: Infectious Immunology Market Pipeline Products 168

Table 72: Microbiology Culture Market Pipeline Products 170

Table 73: Histology and Cytology Market Pipeline Products 171

Table 74: Genetic Testing Market Pipeline Products 172

Table 75: CCS Capital To Acquire Beijing Biochem Hengye Science & Technology Development 174

Table 76: bioMerieux Completes Acquisition Of Meikang Biotech (Shanghai) 175

Table 77: PerkinElmer Completes Acquisition Of Sym-Bio LifeScience 176

Table 78: QIAGEN Enters Into Distribution Agreement With Celera 177

Table 79: Sequenom Enters Into Licensing Agreement With Optherion 178

Table 80: QIAGEN Enters Into Licensing Agreement With Johns Hopkins University 179

Table 81: Response Biomedical Enters Into An Agreement With Guangzhou Wondfo Biotech 180

Table 82: OraSure Technologies Enters Into An Agreement With Roche Diagnostics 181

Table 83: Inverness Medical Innovations Enters Into Distribution Agreement With Epocal 182

Table 84: DxS Signs Cross-Licensing Agreement With Epigenomics 183

Table 85: USD to Local Currency, China, Average Actual Rate 2002-2009 200

1.2 List of Figures

Figure 1: In Vitro Diagnostics, Market Segmentation 17

Figure 2: In Vitro Diagnostics, China, Overall Revenue ($m), 2002-2016 18

Figure 3: In Vitro Diagnostics Market, China, Revenue Mix ($m), 2009 20

Figure 4: In Vitro Diagnostics Market, China, Category Contribution (%), 2009 21

Figure 5: In Vitro Diagnostics, China, Cross-Category Analysis, 2002-2016 22

Figure 6: In Vitro Diagnostics, China, Overall Revenue ($m), Historic, 2002-2009 23

Figure 7: In Vitro Diagnostics, China, Overall Revenue ($m), Forecast, 2009-2016 25

Figure 8: In Vitro Diagnostics, China, Company Share (%), 2009 27

Figure 9: Clinical Chemistry, Market Segmentation 28

Figure 10: Clinical Chemistry Market, China, Revenue Mix ($m), 2009 29

Figure 11: Clinical Chemistry Market, China, Category Contribution (%), 2009 30

Figure 12: Clinical Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 31

Figure 13: Clinical Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 33

Figure 14: Clinical Chemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 35

Figure 15: Clinical Chemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 37

Figure 16: Urine Analysis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 39

Figure 17: Urine Analysis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 41

Figure 18: Clinical Chemistry, China, Company Share (%), 2009 44

Figure 19: Genetic Testing, Market Segmentation 46

Figure 20: Genetic Testing Market, China, Revenue Mix ($m), 2009 47

Figure 21: Genetic Testing Market, China, Category Contribution (%), 2009 48

Figure 22: Genetic Testing, China, Revenue ($m) by Segment, Historic, 2002-2009 49

Figure 23: Genetic Testing, China, Revenue ($m) by Segment, Forecast, 2009-2016 51

Figure 24: Genetic Testing, China, Company Share (%), 2009 54

Figure 25: Haematology, Market Segmentation 55

Figure 26: Haematology Market, China, Revenue Mix ($m), 2009 56

Figure 27: Haematology Market, China, Category Contribution (%), 2009 57

Figure 28: Haematology, China, Revenue ($m) by Segment, Historic, 2002-2009 58

Figure 29: Haematology, China, Revenue ($m) by Segment, Forecast, 2009-2016 60

Figure 30: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 62

Figure 31: Haematology Reagents, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 64

Figure 32: Immunohaematology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 66

Figure 33: Immunohaematology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 68

Figure 34: Haemostasis, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 70

Figure 35: Haemostasis, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 72

Figure 36: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 74

Figure 37: Haematology Rapid Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 76

Figure 38: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 78

Figure 39: Haematology Cell Counters, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 80

Figure 40: Haematology, China, Company Share (%), 2009 83

Figure 41: Histology And Cytology, Market Segmentation 85

Figure 42: Histology And Cytology Market, China, Revenue Mix ($m), 2009 86

Figure 43: Histology And Cytology Market, China, Category Contribution (%), 2009 87

Figure 44: Histology And Cytology, China, Revenue ($m) by Segment, Historic, 2002-2009 88

Figure 45: Histology And Cytology, China, Revenue ($m) by Segment, Forecast, 2009-2016 90

Figure 46: Histology, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 92

Figure 47: Histology, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 94

Figure 48: Histology And Cytology, China, Company Share (%), 2009 97

Figure 49: Immuno Chemistry, Market Segmentation 98

Figure 50: Immuno Chemistry Market, China, Revenue Mix ($m), 2009 99

Figure 51: Immuno Chemistry Market, China, Category Contribution (%), 2009 100

Figure 52: Immuno Chemistry, China, Revenue ($m) by Segment, Historic, 2002-2009 101

Figure 53: Immuno Chemistry, China, Revenue ($m) by Segment, Forecast, 2009-2016 103

Figure 54: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 105

Figure 55: Disease Specific Immunochemistry, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 107

Figure 56: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 109

Figure 57: Drug Related Testing, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 110

Figure 58: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 112

Figure 59: Endocrinology Tests, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 114

Figure 60: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 116

Figure 61: Immunochemistry Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 118

Figure 62: Immuno Chemistry, China, Company Share (%), 2009 121

Figure 63: Infectious Immunology, Market Segmentation 123

Figure 64: Infectious Immunology Market, China, Revenue Mix ($m), 2009 124

Figure 65: Infectious Immunology Market, China, Category Contribution (%), 2009 125

Figure 66: Infectious Immunology, China, Revenue ($m) by Segment, Historic, 2002-2009 126

Figure 67: Infectious Immunology, China, Revenue ($m) by Segment, Forecast, 2009-2016 128

Figure 68: Infectious Immunology, China, Company Share (%), 2009 131

Figure 69: Microbiology Culture, Market Segmentation 133

Figure 70: Microbiology Culture Market, China, Revenue Mix ($m), 2009 134

Figure 71: Microbiology Culture Market, China, Category Contribution (%), 2009 135

Figure 72: Microbiology Culture, China, Revenue ($m) by Segment, Historic, 2002-2009 136

Figure 73: Microbiology Culture, China, Revenue ($m) by Segment, Forecast, 2009-2016 138

Figure 74: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Historic, 2002-2009 140

Figure 75: Microbiology Analyzers, China, Revenue ($m) by Sub-Segment, Forecast, 2009-2016 142

Figure 76: Microbiology Culture, China, Company Share (%), 2009 144

Figure 77: F. Hoffmann-La Roche Ltd., Company Share (%),China In Vitro Diagnostics Market, 2009 145

Figure 78: Siemens Healthcare, Company Share (%),China In Vitro Diagnostics Market, 2009 146

Figure 79: Abbott Laboratories, Company Share (%),China In Vitro Diagnostics Market, 2009 147

Figure 80: Beckman Coulter, Inc., Company Share (%),China In Vitro Diagnostics Market, 2009 148

Figure 81: Sysmex Corporation, Company Share (%),China In Vitro Diagnostics Market, 2009 149

Figure 82: Mindray Medical International Limited, Company Share (%),China In Vitro Diagnostics Market, 2009 150

Figure 83: GlobalData Methodology 197

Companies mentioned F. Hoffmann-La Roche Ltd.

Siemens Healthcare

Abbott Laboratories Company Overview

Beckman Coulter, Inc.

Sysmex Corporation

Mindray Medical International Limited

OLYMPUS CORPORATION

Inverness Medical Innovations, Inc.

Becton, Dickinson and Company

bioMerieux S.A.

Bio-Rad Laboratories, Inc.

Hologic, Inc.

Ventana Medical Systems, Inc.

Ortho-Clinical Diagnostics Inc.

DiaSorin S.p.A

Qiagen N.V.

Gen-Probe Incorporated

Phadia AB

Chengdu Perlong Medical Equipment Co., Ltd.

Shanghai Kehua Bio-engineering Co., Ltd.

China Medical Technologies, Inc.

Shanghai Genomics, Inc.

Beijing Chemclin Biotech Co., Ltd.

Beijing Pason Pharmaceuticals Inc.

Jingmei Biotech Co.,Ltd.

Beijing Bio-Ekon Biotechnology Co., Ltd.

China Sky One Medical, Inc.

Beijing Sekisui Trank Medical Technology Co., Ltd.

Shanghai Xunda Medical Instrument Co.,Ltd

Shanghai Fosun Medical Technology Development Co., Ltd.

Sichuan Nigale Biomedical Inc.

URIT Medical Electronic Group Co., Ltd

Rayto Life and Analytical Sciences Co., Ltd.

Bioson Corporation

Da An Gene Co., Ltd.

Shenzhen PG Biotech Co., Ltd.

Harbin First Bio-Engineering Co., Ltd

Beijing Shining Sun Technology Co., Ltd.

InTec Products, Inc

Zhongshan Bio-Tech Co., Ltd

Beijing BGI-GBI Biotech Co.,Ltd.

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.,

GUANG ZHOU BGH BIOCHEMICAL CO.,LTD

To order this report:

In Vitro Diagnostic Industry: China In Vitro Diagnostics Market Outlook to 2016

In Vitro Diagnostic Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved


Related biology technology :

1. Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
2. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
3. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
4. Reportlinker Adds Proteomics: Technologies and Global Markets Report
5. Reportlinker Adds Nanomedicine Report
6. Reportlinker Adds Small Molecule Kinase Inhibitors Report
7. Reportlinker Adds Nanoporous Materials Report
8. Reportlinker Adds Membrane Bioreactors Report
9. Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement
10. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
11. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016 Savannah River ... technologies and selected NewTechBio,s NT-MAX Lake & ... based beneficial bacteria, in conjunction with Hexa Armor/ ... deficiencies with National Pollutant Discharge Elimination System requirements. ... experienced a steady history of elevated pH levels, ...
(Date:12/8/2016)... PHILADELPHIA , Dec. 8, 2016  Partnering to ... ecosystem, Ben Franklin Technology Partners of Southeastern ... Group ("IHG"), the parent company of Independence Blue Cross; ... today announced their intentions for a $6 million funding ... early-stage healthcare startups. Responding to a burgeoning ...
(Date:12/7/2016)... ... 07, 2016 , ... ACEA Biosciences, Inc. presented today updated ... trial for its lead drug candidate, AC0010, at the World Conference on Lung ... determine the safety, antitumor activity, and recommended phase II dosage of AC0010 in ...
(Date:12/7/2016)... ... December 07, 2016 , ... Huffman Engineering, ... become a Wonderware Certified System Integrator Partner. Huffman Engineering is the only ... , “The System Integrator Partner certification gives customers confidence that our engineers are ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/20/2016)... June 20, 2016 Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring ... involved, it has secured the final acceptance by ... for Managed Access Systems (MAS) installed. Furthermore, Securus ... to be installed by October, 2016. MAS distinguishes ...
Breaking Biology News(10 mins):